Tag: CytRx Corp

  • NASDAQ gainers: GT Advanced Technologies (NASDAQ:GTAT), Tesla Motors (NASDAQ:TSLA), CytRx Corporation (NASDAQ:CYTR), The Fresh Market (NASDAQ:TFM)

    GT Advanced Technologies Inc. (NASDAQ:GTAT) recently announced a technology that will enable solar companies increase the efficiency of their panels besides lowering the manufacturing and installation costs involved in the product of the solar panels. GT Advanced Technologies Inc. (NASDAQ:GTAT) shares after opening at $18.13 moved to $19.34 on last trade day and at the end of the day closed at $18.67. Company price to sales ratio in past twelve months was calculated as 8.40 and price to cash ratio as 5.04. GT Advanced Technologies Inc. (NASDAQ:GTAT) showed a positive weekly performance of 14.04%.

    The electric car company Tesla Motors Inc. (NASDAQ:TSLA) has filed notice that it intends to go to court to appeal New Jersey’s ruling that would stop it from selling its vehicles in the state within two weeks. Tesla Motors Inc. (NASDAQ:TSLA) shares advanced 6.14% in last trading session and ended the day on $230.29. TSLA return on equity ratio is recorded as -14.60% and its return on assets is -3.90%. Tesla Motors Inc. (NASDAQ:TSLA) yearly performance is 460.32%.

    CytRx Corporation (NASDAQ:CYTR) on Mar. 31 announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. CytRx Corporation (NASDAQ:CYTR) shares moved up 6.13% in last trading session and was closed at $3.81, while trading in range of $3.56 – $3.84. CytRx Corporation (NASDAQ:CYTR) year to date (YTD) performance is -39.23%.

    A decision by The Fresh Market (NASDAQ:TFM) to open stores earlier is “part defensive and part offensive,” said Sterne Agee analyst Charles Grom in a research note Wednesday. The Fresh Market Inc. (NASDAQ:TFM) weekly performance is 10.07%. On last trading day company shares ended up $36.83. The Fresh Market Inc. (NASDAQ:TFM) distance from 50-day simple moving average (SMA50) is 7.63%. Analysts mean target price for the company is $39.80.